CPMV OTC
Mosaic ImmunoEngineering Inc.
1W: +73.3%
1M: -8.1%
3M: -84.3%
YTD: -66.0%
1Y: -84.9%
3Y: -88.3%
5Y: -93.7%
$0.11
+0.04 (+73.77%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.8M
52W Range0.054-1.05
Volume16
Avg Volume455
Beta-0.81
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSteven W. King
Employees7
SectorHealthcare
IndustryBiotechnology
IPO Date2013-01-02
Websitemosaicie.com
9114 Adams Avenue
Huntington Beach, CA 92646
US
Huntington Beach, CA 92646
US
657-208-0890
About Mosaic ImmunoEngineering Inc.
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| KING STEVEN W | J-Other | 0 | — | 2022-02-18 |
| FELCYN GLORIA | J-Other | 0 | — | 2022-02-18 |
| GARNICK ROBERT L | J-Other | 0 | — | 2022-02-18 |
| BAFFI ROBERT | J-Other | 0 | — | 2022-02-18 |
| Steinmetz Nicole Fra | J-Other | 0 | — | 2022-02-18 |